Advertisement
Screener

Elequin Capital, LP Historic Quarter Change: Foreign ADRs, Sold Out

Elequin Capital, LP historic quarter change: Foreign ADRs, Sold out

In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), over 10 quarters from 2023-12-31 to 2026-06-30, Elequin Capital, LP opened 3 positions, added to 1, reduced 1 and sold out of 4.

  • Q2 2026: Stock ASCENDIS PHARMA A/S; Country of operation —; Class SPONSORED ADR; Shares before 21.
  • Q3 2025: Stock TOTALENERGIES SE; Country of operation —; Class SPONSORED ADS; Shares before 1.
  • Q1 2025: Stock ASCENDIS PHARMA A/S; Country of operation —; Class SPONSORED ADR; Shares before 53.
  • Q2 2024: Stock ASCENDIS PHARMA A/S; Country of operation —; Class SPONSORED ADR; Shares before 50.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1810873), 10 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-13); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-11); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-11); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-13); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-18); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-12); Q1 2024 (2023-12-31 to 2024-03-31, filed 2025-03-11). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2021-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q2 2026ASCENDIS PHARMA A/S
CUSIP 04351P101
SPONSORED ADR210-21$4,803$0-$4,8032026-08-13
Q3 2025TOTALENERGIES SE
CUSIP 89151E109
SPONSORED ADS10-1$61$0-$612025-11-14
Q1 2025ASCENDIS PHARMA A/S
CUSIP 04351P101
SPONSORED ADR530-53$7,297$0-$7,2972025-05-13
Q2 2024ASCENDIS PHARMA A/S
CUSIP 04351P101
SPONSORED ADR500-50$7,559$0-$7,5592024-08-12

Similar Firms

Firm NameCountry13F ValueHoldings
Talbot Financial, LLCUnited States$1.190B66
BRANDYWINE OAK PRIVATE WEALTH LLCUnited States$1.190B229
Sone Capital Management, LLCUnited States$1.191B101
PKO Investment Management Joint-Stock CoPoland$1.188B220
Concentric Capital Strategies, LPUnited States$1.187B312
Koss-Olinger Consulting, LLCUnited States$1.193B254
TCV Trust & Wealth Management, Inc.United States$1.193B400
KLCM Advisors, Inc.United States$1.185B282
Parvus Asset Management Jersey LtdJersey$1.184B1
ARS Wealth Advisors Group, LLCUnited States$1.184B201